[go: up one dir, main page]

WO2001097750A3 - Procede de fabrication d'un produit antiviral - Google Patents

Procede de fabrication d'un produit antiviral Download PDF

Info

Publication number
WO2001097750A3
WO2001097750A3 PCT/RU2001/000255 RU0100255W WO0197750A3 WO 2001097750 A3 WO2001097750 A3 WO 2001097750A3 RU 0100255 W RU0100255 W RU 0100255W WO 0197750 A3 WO0197750 A3 WO 0197750A3
Authority
WO
WIPO (PCT)
Prior art keywords
producing
antiviral agent
lignin
medicinal
inventive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/RU2001/000255
Other languages
English (en)
Russian (ru)
Other versions
WO2001097750A2 (fr
Inventor
Valery Afanasievich D Trofimov
Valery Pavlovich Shipov
Evgeny Sergeevich Pigarev
Aleksandr Ivanovich Popov
Viktor Nikolaevich Ivanov
Galina Sergeevna Shitikova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nobel LLC
Original Assignee
Nobel LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nobel LLC filed Critical Nobel LLC
Priority to AU2001277823A priority Critical patent/AU2001277823A1/en
Publication of WO2001097750A2 publication Critical patent/WO2001097750A2/fr
Publication of WO2001097750A3 publication Critical patent/WO2001097750A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Le procédé de fabrication d'un produit antiviral de l'invention consiste à traiter un platinide de sodium avec du sel d'ammonium de l'acide carbonique; on utilise à cet effet des acides humiques obtenus à partir de la lignine oxydée à usage médical, que l'on fabrique par l'oxydation de la lignine oxydée avec de l'oxygène contenu dans l'air, dans un milieu aqueux de base à une température entre 150° et 170 °C et une pression entre 2,0 et 2,5 MPa pendant 0,5 heure à 1,5 heure. La préparation ainsi obtenue manifeste une activité antivirale fortement prononcée dirigée contre les virus de l'herpès simple des sérotypes 1 et 2, de la grippe et du sarcome de Rous.
PCT/RU2001/000255 2000-06-19 2001-06-15 Procede de fabrication d'un produit antiviral Ceased WO2001097750A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001277823A AU2001277823A1 (en) 2000-06-19 2001-06-15 Method for producing an antiviral agent

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2000115399 2000-06-19
RU2000115399/14A RU2172176C1 (ru) 2000-06-19 2000-06-19 Способ получения противовирусного средства

Publications (2)

Publication Number Publication Date
WO2001097750A2 WO2001097750A2 (fr) 2001-12-27
WO2001097750A3 true WO2001097750A3 (fr) 2002-03-07

Family

ID=20236225

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU2001/000255 Ceased WO2001097750A2 (fr) 2000-06-19 2001-06-15 Procede de fabrication d'un produit antiviral

Country Status (3)

Country Link
AU (1) AU2001277823A1 (fr)
RU (1) RU2172176C1 (fr)
WO (1) WO2001097750A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104245800A (zh) * 2012-03-30 2014-12-24 Rd创新有限公司 新苯聚羧酸化合物

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2178702C1 (ru) * 2001-02-21 2002-01-27 Общество с ограниченной ответственностью "Нобель" Антираковое средство
RU2678986C1 (ru) * 2018-03-23 2019-02-05 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора) Противовирусное средство на основе гуминовых кислот

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419351A (en) * 1977-06-03 1983-12-06 Research Corporation Platinum-dioxopyrimidine complexes
US4873226A (en) * 1983-06-17 1989-10-10 Delta Metals, Inc. Method of inhibiting herpetic lesions by the use of platinum coordination compounds
RU2104016C1 (ru) * 1990-05-27 1998-02-10 Шантал Мах Способ получения водного раствора, содержащего активные вещества антивирусного действия

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419351A (en) * 1977-06-03 1983-12-06 Research Corporation Platinum-dioxopyrimidine complexes
US4873226A (en) * 1983-06-17 1989-10-10 Delta Metals, Inc. Method of inhibiting herpetic lesions by the use of platinum coordination compounds
RU2104016C1 (ru) * 1990-05-27 1998-02-10 Шантал Мах Способ получения водного раствора, содержащего активные вещества антивирусного действия

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
IZOBRETENIYA, no. 1, 10 January 1997 (1997-01-10), MOSCOW, VNIIPI, pages 22 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104245800A (zh) * 2012-03-30 2014-12-24 Rd创新有限公司 新苯聚羧酸化合物

Also Published As

Publication number Publication date
RU2172176C1 (ru) 2001-08-20
AU2001277823A1 (en) 2002-01-02
WO2001097750A2 (fr) 2001-12-27

Similar Documents

Publication Publication Date Title
EP0786458A3 (fr) Dérivés et analogues d'acide 2-déoxy-2,3-didéhydro-N-acétyle neuraminique et leur utilisation comme agents antiviraux
AU2002311886A1 (en) Process for preparing purified shilajit composition from native shilajit
CA2225764A1 (fr) Methode de fabrication d'un tuteur et appareil
WO2001047928A3 (fr) Nouveaux imidazo[1,3,5]triazinones et leur utilisation
CA2342033A1 (fr) Technique et appareil d'amelioration de l'efficacite d'un compresseur a plusieurs etages
CA2332756A1 (fr) Methode de fabrication de composes d'insertion expansibles en graphite a l'aide d'acides phosphoriques
EP0846447A3 (fr) Procédé de fabrication d'un stent
WO2000023407A3 (fr) Composes chimiques
CA2258768A1 (fr) Procede pour la preparation de tetraazamacrocycles
EP1203765A3 (fr) Procédé de préparation d'urée
AU6194998A (en) Aqueous cosmetic composition containing stably solubilized uric acid and water-soluble polymer and method for stably solubilizing uric acid in aqueous cosmetic composition
WO2003032907A3 (fr) Formulations a haute teneur en proteines et procede de production
EP0885881A3 (fr) Dérivés d'acide sulfamique sulfonylalkanoylaminohydroxyéthylamino utiles comme inhibiteurs des protéases rétrovirales
WO2003044210A3 (fr) Elaboration de composes insuliniques
MY140392A (en) Powder of amino acids and method for producing the same
WO2001097750A3 (fr) Procede de fabrication d'un produit antiviral
EP0670371A3 (fr) Procédé de préparation des acides 4-hydroxy-2-ketoglutarique optiquement actifs
WO2002000615A3 (fr) Procede d'isolation de lovastatine
ES2184302T3 (es) Procedimiento para la preparacion del acido 1,4,7,10-tetraazaciclododecano-1,4,7-triacetico y derivados del mismo.
AU5209900A (en) Copolymers with amphiphilic sub-units, a method for producing the same and the use thereof
WO1994028153A3 (fr) Adn de faible masse moleculaire tiree de laitance d'esturgeon, procede d'obtention de l'adn et preparation pharmaceutique a base de celui-ci
EP1112999A3 (fr) Réduction d'azides en amines à l'aide de phosphines
EP1415985A4 (fr) Procede de production d'acide azetidine-2-carboxylique optiquement actif
AU6878900A (en) 1,4-dihydropyridine-5-carboxylic acid ester derivatives and method for the preparation thereof
WO2001060858A3 (fr) Procede de preparation de proteine cationique eosinophile de muqueuse (ecp), ecp de muqueuse, et ses utilisations comme marqueur des phlogoses allergiques

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AT AU BG BR CA CN CZ DE DK EE ES FI GB GE HR HU IL IN IS JP KE KR KZ LT LV NO NZ PL PT SE SK TR UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AT AU BG BR CA CN CZ DE DK EE ES FI GB GE HR HU IL IN IS JP KE KR KZ LT LV NO NZ PL PT SE SK TR UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC.(EPO LETTER FORM 1205A HAS BEEN SENT ON 10/06/2003)

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP